Fearing Chinese Rivals, U.S. Biotech Adopts a New Norm: Share Nothing

4 days ago 21

Science|Fearing Chinese Rivals, U.S. Biotech Adopts a New Norm: Share Nothing

https://www.nytimes.com/2026/11/17/science/fearing-chinese-rivals-us-biotech-adopts-a-new-norm-share-nothing.html

You person a preview presumption of this nonfiction portion we are checking your access. When we person confirmed access, the afloat nonfiction contented volition load.

Concerns that well-funded Chinese companies volition swoop successful to drawback caller ideas for their ain cause improvement are shaping an manufacture unaccustomed to specified secrecy.

A idiosyncratic   wearing a achromatic  laboratory  overgarment  and glasses stands wrong  a laboratory, viewed done  a window. Metal instrumentality  and containers situation   them.
Fears that Chinese companies volition prehend connected biotech discoveries successful the U.S. and rapidly bushed them to marketplace with their ain inventions oregon somewhat altered dupes person prompted American companies to support their discoveries secret.Credit...Florence Lo/Reuters

Gina Kolata

By Gina Kolata

Gina Kolata spoke to 18 biotech executives and investors and work testimonies and reports to Congress connected the China challenge.

Nov. 17, 2026, 5:01 a.m. ET

It utilized to beryllium that companies and scientists with ideas for caller drugs couldn’t hold to denote their discoveries astatine meetings, successful preprints and connected their websites.

That is changing.

Researchers astatine the biotechnology steadfast Alnylam Pharmaceuticals person an unwritten policy: Do not uncover early-stage studies oregon sermon unpublished data, according to its founding main executive, Dr. Christoph Westphal.

Jacob Becraft of Strand Therapeutics delays filing for patents to support his company’s discoveries secret. And helium is cautious astir disclosing his company’s intelligence spot and confidential material, adjacent to investors.

Alexis Borisy, a co-founder of Curie.Bio, which helps early-stage biotechs, says helium tells scientists to “go dark” — don’t publish, don’t contiguous posters astatine meetings, don’t adjacent spell to meetings.

The crushed for this guarded stance? Fears that Chinese companies volition prehend connected the biotechs’ discoveries and rapidly bushed them to marketplace with the U.S. firms’ ain inventions oregon with somewhat altered versions that dilute marketplace exclusivity.

“This is the satellite we’re successful now,” Mr. Borisy said. Meetings are wherever scientists sermon caller ideas. Publication is the lifeblood of science. But now, being excessively unfastened excessively soon has go excessively risky, helium and others said.


Thank you for your patience portion we verify access. If you are successful Reader mode delight exit and log into your Times account, or subscribe for each of The Times.


Thank you for your patience portion we verify access.

Already a subscriber? Log in.

Want each of The Times? Subscribe.

Read Entire Article